Goodwin

Graham Defries

Deals
2
Latest
Jul 2026
Most deals in
Biotech

Firm

  • Goodwin Law firm · 2026 · 2 deals

Often works with

Deals

Deals dated after 30 September 2026 are still being collected.

Columns
Deals Graham Defries was named on, most recent first
Jul 2026 Memo Therapeutics –IpsenAcquisitionLegal adviser to Memo Therapeutics AG (target)Announced231.1BiotechIpsen acquisition of Memo Therapeutics
Apr 2026 Tubulis EQT Life Sciences (LSP 7 fund)Gilead SciencesAcquisitionLegal adviser to Tubulis (target)Announced3,150.0Biotech+2Gilead Sciences acquisition of Tubulis

Deals where Graham Defries is named on the firm's deal team, by the firm or the press.

Suggest a correction

A missing deal, a wrong firm, a move between firms, or two different people shown as one. A link to a public source helps.